Jagsonpal Pharmaceuticals Limited
Share Price Target & Analysis

NSE:JAGSNPHARM

204.55

VWAP

205

Open

201.75

Close

206.18

High

201.01

Low

301.65

52 Week High

204.53 ⇧
2.78 (1.38%)

JAGSNPHARM

(PHARMA)
33.8% Momentum

Turnaround Potential

155

52 Week Low

6.54

EPS

47.91

PE

5.11

PB

Economical
Quality

Gold
Valuation

#Analysis

NSE: JAGSNPHARM Share Price Financial Analysis & Valuation

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Micro Cap company with Market Capitalization of Rs 423.1 (in Cr). Total number of free float shares are 2.6 (in Lacs). Jagsonpal Pharmaceuticals Limited is listed on NSE with Exchange ID - INE048B01035 and trading code is NSE:JAGSNPHARM with short name JagsonpalPharma.

In the past 1 year, Jagsonpal Pharmaceuticals Limited has declared an equity dividend of Rs 4 per share. At the current share price of JAGSNPHARM at Rs 204.53, this results in a dividend yield of 1.96 %.

As per the Fundamental Analysis of NSE:JAGSNPHARM, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine JAGSNPHARM underlying value and future prospects. All of this data is available in JAGSNPHARM financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:JAGSNPHARM, it is clearly understood that JAGSNPHARM is Economical performer in terms of earnings and profit margins with an EPS of 6.54. NSE:JAGSNPHARM book value per share as of today is 40.04. The current price to book ratio for JAGSNPHARM as of Jun 10, 2026 is 5.11.

Valuation of the Stock: The current valuation of JAGSNPHARM stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of JAGSNPHARM whether to BUY this stock at current valuation. The delivery percentage of JAGSNPHARM is 44.37% is very crucial parameter which shows that 44.37% investors are anticipating that the price of JAGSNPHARM share should go up with VWAP at 204.55.

Now, the main question is whether to BUY or SELL, NSE:JAGSNPHARM at current valuation.
As per latest Analysis No. #1274:-

⇑ STRONG BUY JAGSNPHARM if All Greens

⇗ BUY JAGSNPHARM (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD JAGSNPHARM (With Stop Loss) if only 1 Green

⇘ SELL JAGSNPHARM if NO Green Indicator

NSE: JAGSNPHARM Share Price Today (Jun 10, 2026)

(Jagsonpal Pharmaceuticals Limited Daily Analysis on the basis of JAGSNPHARM Intraday Graph & Trend)

Jagsonpal Pharmaceuticals Limited share price moved Up by 1.38% from its previous close of Rs 201.75. JAGSNPHARM stock last traded price is 204.53. JAGSNPHARM share price trend is Up with a total of 58039 stocks traded till now. It has touched an intraday high of Rs 206.18 and an intraday low of Rs 201.01. The JAGSNPHARM trading at 204.53, Up by Rs. 2.78, or 1.38 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Up.

NSE: JAGSNPHARM Share Price Tomorrow Prediction

(Jagsonpal Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of JAGSNPHARM)

Jagsonpal Pharmaceuticals Limited share price moved Up by 1.38%. JAGSNPHARM share price short term trend is Up. It suggests that JAGSNPHARM Share Price for Tomorrow remains the same with VWAP at 204.55 will be treated as stop loss for intraday traders. Jagsonpal Pharmaceuticals Limited Long term investors can follow the JAGSNPHARM long term trend as mentiond in future forecast table.

NSE Code

NSE: JAGSNPHARM

JAGSNPHARM Share Price Today

 204.53

JAGSNPHARM Share Price Target Prediction for 2026 ^

 162.5 - 242.6

JAGSNPHARM Share Price Target Prediction for 2027*^

 242.6 - 322.9

JAGSNPHARM Share Price Target Prediction for 2028*^

 322.9 - 345.5

JAGSNPHARM Share Price Target Prediction for 2029*^

 363

JAGSNPHARM Share Price Target Prediction for 2030*^

 373

JAGSNPHARM Share Price Target Prediction for 2035*^

 407
JAGSNPHARM Current Book Value 2025
39.8

*Jagsonpal Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^JAGSNPHARM share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

JAGSNPHARM Technical Analysis

Candlestick Pattern: @242.09

JAGSNPHARM Moving Averages

BUY (14) NEUTRAL (0) SELL (0)
MA Simple Action S1 Expo Action E2
MA_5 232.65 BUY 233.93 BUY
MA_12 227.82 BUY 229.75 BUY
MA_20 225.18 BUY 228.36 BUY
MA_32 228.69 BUY 227.05 BUY
MA_50 225.32 BUY 226.3 BUY
MA_100 222.47 BUY 225.25 BUY
MA_200 225.94 BUY 216.1 BUY

JAGSNPHARM Trend Oscillators

BUY (3) NEUTRAL (1) SELL (0)
Trend Oscillators Value Action
Bollinger Bands 239.31 OverBought
MACD 1.56 BUY
ADX 12.83 NO or Weak Trend
DMI (+/-) 28.33 / 12.76 Uptrend

JAGSNPHARM Momentum Oscillators

BUY (7) NEUTRAL (5) SELL (0)
Momentum Oscillators Value Action
RSI 66.74 Neutral
STOCHASTIC_K (Fast) 68.02 Neutral
STOCHASTIC_D (Slow) 63.92 Neutral
CCI 167.98 BUY
PSAR 215.74 BUY
TRUE RANGE 23 BUY
ATR 8.63 BUY
WILLIAMS R -18.43 Overbought
TRIX 0 Neutral
STOCHASTIC RSI K 100 Overbought
STOCHASTIC RSI D 59.83 Neutral
MOMENTUM 7.07 BUY

JAGSNPHARM Last 1 Year Trend

Duration Value
1 Year 79.57%
3 Months 19.33%
1 Month 3.01%
1 Week 4.76%

JAGSNPHARM Technical Analysis Summary

Updated on 2025-07-11
Action Overall (%)
BUY 80%
NEUTRAL / HOLD 20%
SELL 0%

Most popular Questions & Answers about JAGSNPHARM


Jagsonpal Pharmaceuticals Limited stock last traded price is 204.53. JAGSNPHARM share price moved Up by 1.38% from its previous close of Rs 201.75.

Jagsonpal Pharmaceuticals Limited share price trend is Up with a total of 58039 stocks traded till now. It has touched an intraday high of Rs 304.6665 and an intraday low of Rs 201.01. The JAGSNPHARM trading at 204.53, Up by Rs. 2.78, or 1.38 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Up and the Stop Loss will be around 204.55.

The market cap of Jagsonpal Pharmaceuticals Limited is ₹423.1 (in Cr) as of Jun 09, 2026.

The current price to earning ratio for Jagsonpal Pharmaceuticals Limited as of Jun 09, 2026 is 47.91.

The current price to book ratio for Jagsonpal Pharmaceuticals Limited as of Jun 09, 2026 is 5.11.

The highest price of Jagsonpal Pharmaceuticals Limited stock is ₹301.65 in the last 52-week.

The lowest price of Jagsonpal Pharmaceuticals Limited stock is ₹155 in the last 52-week.

Jagsonpal Pharmaceuticals Limited share trading at ₹204.53, Up by Rs. 2.78, or 1.38 percent which suggests that most of the traders are anticipating that the price of JAGSNPHARM share should go Up.

In 2025, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹162.5 on downside and ₹242.6 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on current financial year earings of the company.

In 2026, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹242.6 on downside and ₹322.9 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.

In 2027, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹322.9 on downside and ₹345.5 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) will be around ₹373 Jagsonpal Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of JAGSNPHARM.

The price of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) shares moved by 1.38%. The short-term trend for JAGSNPHARM share price is Up. It implies that the share price of JAGSNPHARM will stay the same tomorrow and that intraday traders should treat VWAP at 204.55 as a stop loss. Investors with a long-term outlook can track JAGSNPHARM long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of JAGSNPHARM stock is 78.4. Compared to the current market price of 204.53 INR, the JAGSNPHARM stock is Overvalued by 61.7%.

As per the fundamental analysis of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM), it is of Economical quality in terms of earnings and profit margins with an EPS of 6.54. Jagsonpal Pharmaceuticals Limited book value per share as of today is 40.04. The current price to book ratio for JAGSNPHARM as of Jun 10, 2026 is 5.11.


NSE:JAGSNPHARM News & Other Useful Information about JAGSNPHARM Share Price


Peer Comparison of NSE: JAGSNPHARM

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1786.40 10.97 102.19
DIVISLAB 6638.50 98.2 600.79
MEDICAMEQ 230.10 6.94 202.47
CIPLA 1377.00 43.51 419.16
DRREDDY 1271.70 38.57 378.63
PGHH 5215.00 189.8 373.34
TORNTPHARM 4463.70 64.77 266.87
BIOCON 414.60 0.23 99.01
LUPIN 2247.20 139.24 611.12
ALKEM 5299.50 190.87 1194.91
Updated at: 10 Jun 2026 15:50

Feel free to contact us, in case of any queries.

SITEMAP 8857
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2931.10 -48.80 (-1.64%) | ADANIGREEN 1483.00 -51.50 (-3.36%) | ADANIPORTS 1821.20 -5.20 (-0.28%) | ADANITRANS 988.50 0.35 (0.04%) | AMBUJACEM 409.80 -6.20 (-1.49%) | APOLLOHOSP 8488.50 -35.50 (-0.42%) | ASIANPAINT 2715.10 7.00 (0.26%) | ATGL 728.40 -23.75 (-3.16%) | AUROPHARMA 1453.60 4.60 (0.32%) | AXISBANK 1314.50 22.10 (1.71%) | BAJAJ-AUTO 10144.00 -40.00 (-0.39%) | BAJAJFINSV 1664.20 -28.90 (-1.71%) | BAJFINANCE 884.10 -2.80 (-0.32%) | BALKRISIND 2083.20 -44.60 (-2.1%) | BANDHANBNK 199.76 -7.18 (-3.47%) | BANKBARODA 269.30 -4.45 (-1.63%) | BEL 408.35 -3.70 (-0.9%) | BERGEPAINT 516.70 14.80 (2.95%) | BHARTIARTL 1775.20 -23.80 (-1.32%) | BIOCON 414.60 -1.75 (-0.42%) | BOSCHLTD 37790.00 -30.00 (-0.08%) | BPCL 288.00 -1.10 (-0.38%) | BRITANNIA 5171.00 63.50 (1.24%) | CADILAHC 905.25 2.35 (0.26%) | CIPLA 1377.00 0.50 (0.04%) | COALINDIA 451.00 -15.90 (-3.41%) | COLPAL 2056.30 32.90 (1.63%) | DABUR 427.90 1.75 (0.41%) | DIVISLAB 6638.50 -114.50 (-1.7%) | DLF 563.20 -11.95 (-2.08%) | DMART 4043.40 -48.60 (-1.19%) | DRREDDY 1271.70 3.20 (0.25%) | EICHERMOT 7219.50 16.50 (0.23%) | GAIL 168.01 0.42 (0.25%) | GLAND 2267.80 -20.70 (-0.9%) | GODREJCP 1027.60 14.40 (1.42%) | GRASIM 3071.20 -24.30 (-0.79%) | GUJGASLTD 381.30 -10.85 (-2.77%) | HAVELLS 1155.50 5.00 (0.43%) | HCLTECH 1132.10 -14.20 (-1.24%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 2447.80 -55.50 (-2.22%) | HDFCBANK 746.85 8.50 (1.15%) | HDFCLIFE 549.55 -11.05 (-1.97%) | HEROMOTOCO 4856.70 1.30 (0.03%) | HINDALCO 1039.30 -37.40 (-3.47%) | HINDUNILVR 2169.50 36.70 (1.72%) | HINDZINC 547.55 -16.10 (-2.86%) | ICICIBANK 1293.30 18.30 (1.44%) | ICICIGI 1732.20 -45.50 (-2.56%) | ICICIPRULI 465.80 -8.95 (-1.89%) | INDIGO 4524.90 -12.70 (-0.28%) | INDUSINDBK 883.95 -38.85 (-4.21%) | INDUSTOWER 413.15 -6.25 (-1.49%) | INFY 1145.30 -35.00 (-2.97%) | IOB 33.26 -0.17 (-0.51%) | IOC 136.88 -1.25 (-0.9%) | ITC 283.65 3.65 (1.3%) | JSWSTEEL 1269.80 8.10 (0.64%) | KOTAKBANK 388.10 6.40 (1.68%) | LT 3917.50 16.90 (0.43%) | LTI 5706.50 -337.50 (-5.58%) | LUPIN 2247.20 -17.00 (-0.75%) | M&M 2952.50 -37.60 (-1.26%) | MARICO 819.90 6.70 (0.82%) | MARUTI 13073.00 -47.00 (-0.36%) | MCDOWELL-N 1358.10 -8.00 (-0.59%) | MOTHERSUMI 121.00 -1.62 (-1.32%) | MUTHOOTFIN 2898.80 -92.30 (-3.09%) | NAUKRI 971.25 -11.35 (-1.16%) | NESTLEIND 1438.30 27.90 (1.98%) | NMDC 88.45 -1.59 (-1.77%) | NTPC 351.65 -4.00 (-1.12%) | ONGC 251.90 -7.10 (-2.74%) | PEL 1124.20 0.00 (0%) | PIDILITIND 1506.50 24.70 (1.67%) | PIIND 2807.70 -58.70 (-2.05%) | PNB 107.17 -2.48 (-2.26%) | POWERGRID 287.20 1.50 (0.53%) | RELIANCE 1258.80 -10.40 (-0.82%) | SAIL 181.72 -4.27 (-2.3%) | SBICARD 580.70 -4.25 (-0.73%) | SBILIFE 1728.70 -40.40 (-2.28%) | SBIN 1003.25 0.55 (0.05%) | SHREECEM 23850.00 435.00 (1.86%) | SIEMENS 3582.70 -37.10 (-1.02%) | SRF 2734.10 44.50 (1.65%) | SUNPHARMA 1786.40 7.40 (0.42%) | TATACONSUM 1108.00 1.50 (0.14%) | TATAMOTORS 375.45 3.40 (0.91%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 199.31 -3.87 (-1.9%) | TCS 2153.90 2.90 (0.13%) | TECHM 1478.90 -4.90 (-0.33%) | TITAN 4042.10 -62.80 (-1.53%) | TORNTPHARM 4463.70 -9.20 (-0.21%) | ULTRACEMCO 10866.00 -45.00 (-0.41%) | UPL 611.00 -17.40 (-2.77%) | VEDL 299.30 -6.95 (-2.27%) | WIPRO 178.93 -2.74 (-1.51%) |